.

Establishing consensus on the optimal intravitreal treatment pathway for DMO patients in the UK.

Authors: Habib Maged, Dinah Christiana, Mitra Arjit Devonport Helen, Nicholson Luke, Rennie Christina, Grinton Michael, Downey Louise, Bailey Clare, Gale Richard.

Presenting author: Habib MS.

Presentation date and time: Sun 07 Dec at 09:09 am CET.

Plain language Summary

People with diabetes can get swelling in the centre of the eye. This swelling is called diabetic macular oedema. It can make vision blurry and may lead to sight loss. Doctors use two main types of eye injections to treat this: anti-VEGF drugs and steroids. Until now, there has not been clear advice on when to use each one.

UK eye doctors worked together to agree on the best steps. They shared ideas and voted until most agreed. This gave clear guidance for care.

The experts said treatment should be personal for each patient. They agreed on what counts as a poor response. If the swelling improves by less than 10%, the drug is not working. If it improves by 10–20%, the response is still not good enough.

Doctors should check early if anti-VEGF drugs help. This check should happen after three to six months and after trying two types of anti-VEGF drugs. If the eye still does not respond well after nine to twelve months, doctors should switch to steroids. If short-acting steroids work after one or two injections, doctors should move to a longer-lasting steroid.

This advice will help doctors act sooner when treatment is not working and help to get the right treatment at the right time, protect sight and improve care for people with diabetes.

Poster

Presentation Slides